News
As a result, a market for cheaper, off-brand versions of their active ingredients — semaglutide and tirzepatide — has ...
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Compounded GLP-1s are no longer to be sold following the FDA announcement that the shortage of semaglutide and tirzepatide ended.
4h
Extra.ie on MSNWatchdog issues urgent warning over ads for fake weight-loss drugsThe medicines watchdog has issued an urgent warning about a deluge of social media advertisements for counterfeit weight-loss drugs.
HPRA concerned by promotions for ‘made in Ireland’ obesity medications wrongly claiming to be approved by charities, ...
2d
MedPage Today on MSNEnd of Compounded Semaglutide; 464M Teens Will Have Obesity; GLP-1 Scripts SkyrocketResearchers said a single daytime sample of serum 17-hydroxyprogesterone and/or androstenedione is sufficient to monitor ...
Explore the evolving landscape of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for obesity, highlighting access ...
The Health Products Regulatory Authority (HPRA) said that, to date, some 155 Shopify product listings, 124 Facebook profiles, ...
Tirzepatide, the newest weight loss drug in India, is transforming the wellness market with its hormone-mimicking effects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results